Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled, 4-week Study to Evaluate the Safety and Efficacy of T0903131 Besylate in Subjects With Type 2 Diabetes Mellitus

NCT00952445 is registered in ClinicalTrials.gov with InteKrin Therapeutics, Inc. as lead sponsor.

NCT NCT00952445
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00952445 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled, 4-week Study to Evaluate the Safety and Efficacy of T0903131 Besylate in Subjects With Type 2 Diabetes Mellitus
Lead sponsor
InteKrin Therapeutics, Inc.
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2003
Completion date
June 30, 2004
Enrollment
70 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type ii